113 related articles for article (PubMed ID: 6091721)
1. Studies on the incorporation of eicosapentaenoic acid (EPA) into platelet membrane phospholipids and the effects of EPA supplementation on platelet function, skin bleeding time and blood viscosity in man.
Greaves M; Woodcock BE; Galloway JH; Preston FE
Br J Clin Pract Suppl; 1984; 31():45-8. PubMed ID: 6091721
[No Abstract] [Full Text] [Related]
2. In vitro incorporation and metabolism of icosapentaenoic and docosahexaenoic acids in human platelets--effect on aggregation.
Croset M; Lagarde M
Thromb Haemost; 1986 Aug; 56(1):57-62. PubMed ID: 3022414
[TBL] [Abstract][Full Text] [Related]
3. Metabolism and effects on platelet function of the purified eicosapentaenoic and docosahexaenoic acids in humans.
von Schacky C; Weber PC
J Clin Invest; 1985 Dec; 76(6):2446-50. PubMed ID: 3001149
[TBL] [Abstract][Full Text] [Related]
4. Effects of 11-week increases in dietary eicosapentaenoic acid on bleeding time, lipids, and platelet aggregation.
Thorngren M; Gustafson A
Lancet; 1981 Nov; 2(8257):1190-3. PubMed ID: 6118628
[TBL] [Abstract][Full Text] [Related]
5. Biosynthesis of prostanoids, tissue fatty acid composition and thrombotic parameters in rats fed diets enriched with docosahexaenoic (22:6n3) or eicosapentaenoic (20:5n3) acids.
Bruckner GG; Lokesh B; German B; Kinsella JE
Thromb Res; 1984 Jun; 34(6):479-97. PubMed ID: 6330927
[TBL] [Abstract][Full Text] [Related]
6. Effect of oral administration of highly purified eicosapentaenoic acid on platelet function, blood viscosity and red cell deformability in healthy human subjects.
Terano T; Hirai A; Hamazaki T; Kobayashi S; Fujita T; Tamura Y; Kumagai A
Atherosclerosis; 1983 Mar; 46(3):321-31. PubMed ID: 6303363
[TBL] [Abstract][Full Text] [Related]
7. Incorporation of some eicosanoic acids into endothelial cells--effect on platelet inhibitory activity and prostacyclin production.
Sicard B; Lagarde M
Thromb Haemost; 1985 Apr; 53(2):264-7. PubMed ID: 2992114
[TBL] [Abstract][Full Text] [Related]
8. Effects of dietary fish oil supplementation on the fatty acid composition of the human platelet membrane: demonstration of selectivity in the incorporation of eicosapentaenoic acid into membrane phospholipid pools.
Galloway JH; Cartwright IJ; Woodcock BE; Greaves M; Russell RG; Preston FE
Clin Sci (Lond); 1985 Apr; 68(4):449-54. PubMed ID: 2982533
[TBL] [Abstract][Full Text] [Related]
9. Fatty acid-derived lipid mediators and blood platelet aggregation.
Lagarde M; Chen P; Véricel E; Guichardant M
Prostaglandins Leukot Essent Fatty Acids; 2010; 82(4-6):227-30. PubMed ID: 20207119
[TBL] [Abstract][Full Text] [Related]
10. Uptake and effect on arachidonic acid oxygenation of some icosaenoic acids in human platelets.
Lagarde M; Drouot B; Guichardant M; Dechavanne M
Biomed Biochim Acta; 1984; 43(8-9):S319-22. PubMed ID: 6097236
[TBL] [Abstract][Full Text] [Related]
11. Comparative aspects of omega-3 and omega-6 polyunsaturated fatty acids in rabbits and rats: effects on platelet function, thromboxane and prostacyclin generation, tissue phospholipid fatty acids and membrane fluidity.
Bolton-Smith C; Gibney MJ; Vas Dias FW; Hillier K
Br J Clin Pract Suppl; 1984; 31():37-41. PubMed ID: 6091719
[No Abstract] [Full Text] [Related]
12. Dietary supplementation of eicosapentaenoic acid (C20:5 omega-2; EPA), platelet function and blood pressure regulation.
Weber PC
Br J Clin Pract Suppl; 1984; 31():122-5. PubMed ID: 6091717
[No Abstract] [Full Text] [Related]
13. Effect of supplementation of highly purified eicosapentaenoic acid and docosahexaenoic acid on hemostatic function in healthy subjects.
Hirai A; Terano T; Takenaga M; Kobayashi S; Makuta H; Ozawa A; Fujita T; Tamura Y; Kitagawa H; Kumagai A
Adv Prostaglandin Thromboxane Leukot Res; 1987; 17B():838-45. PubMed ID: 2823571
[No Abstract] [Full Text] [Related]
14. Alteration and recovery of bleeding times, platelet aggregation and fatty acid composition of individual phospholipids in platelets of human subjects receiving a supplement of cod-liver oil.
Ahmed AA; Holub BJ
Lipids; 1984 Aug; 19(8):617-24. PubMed ID: 6090856
[TBL] [Abstract][Full Text] [Related]
15. A proposed method for exploring anti-aggregatory effects of eicosapentaenoic acid in the rat.
Morita I; Komeshima N; Takahashi R; Orimo H; Murota S
Prostaglandins Leukot Med; 1984 Apr; 14(1):123-9. PubMed ID: 6328539
[TBL] [Abstract][Full Text] [Related]
16. The effect of albumin bound polyunsaturated fatty acids on human platelets.
Holme S; Brox JH; Krane H; Nordøy A
Thromb Haemost; 1984 Feb; 51(1):32-6. PubMed ID: 6719386
[TBL] [Abstract][Full Text] [Related]
17. [Effects of 4 weeks' intake of polyunsaturated fatty acid ethylester rich in eicosapentaenoic acid (ethylester) on plasma lipids, plasma and platelet phospholipid fatty acid composition and platelet aggregation; a double blind study].
Kawamura M; Naito C; Hayashi H; Hashimoto Y; Kato H; Matsushima T
Nihon Naika Gakkai Zasshi; 1983 Jan; 72(1):18-24. PubMed ID: 6343532
[No Abstract] [Full Text] [Related]
18. Effects of eicosapentaenoic acid on hemostatic function and serum lipids in humans.
Tamura Y; Hirai A; Terano T; Kumagai A; Yoshida S
Adv Prostaglandin Thromboxane Leukot Res; 1985; 15():265-7. PubMed ID: 3004139
[No Abstract] [Full Text] [Related]
19. Studies on the biological balance between thromboxanes and prostacyclins in relation to the platelet-vessel wall interaction.
Jørgensen KA
Dan Med Bull; 1982 May; 29(4):169-97. PubMed ID: 6286257
[No Abstract] [Full Text] [Related]
20. The influence of different types of omega 3 polyunsaturated fatty acids on blood lipids and platelet function in healthy volunteers.
Sanders TA; Roshanai F
Clin Sci (Lond); 1983 Jan; 64(1):91-9. PubMed ID: 6295686
[No Abstract] [Full Text] [Related]
[Next] [New Search]
